Across TCGA pan-cancer cohorts, ZNF100 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ZNF100 data layer compared with 27 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher ZNF100 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ZNF100 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

LUAD and GBM are the cancer types where ZNF100 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.277	1.000	.009	21	view →
GBM	DFS	Tertile	All	0.803	0.395	.003	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: ZNF100 tumor-vs-normal RNA expression · all ZNF100 data types